Acute infective conjunctivitis in primary care: Who needs antibiotics? An individual patient data meta-analysis
Acute infective conjunctivitis in primary care: Who needs antibiotics? An individual patient data meta-analysis
Background: acute infective conjunctivitis is a common problem in primary care, traditionally managed with topical antibiotics. A number of clinical trials have questioned the benefit of topical antibiotics for patients with acute infective conjunctivitis
Aim: to determine the benefit of antibiotics for the treatment of acute infective conjunctivitis in primary care and which subgroups benefit most
Design: an individual patient data meta-analysis
Method: relevant trials were identified and individual patient data gathered for meta-analysis and subgroup analysis
Results: three eligible trials were identified. Individual patient data were available from all primary care trials and data were available for analysis in 622 patients. Eighty per cent (246/308) of patients who received antibiotics and 74% (233/314) of controls were cured at day 7. There was a significant benefit of antibiotics versus control for cure at seven days in all cases combined (risk difference 0.08, 95% confidence interval (CI) = 0.01 to 0.14). Subgroups that showed a significant benefit from antibiotics were patients with purulent discharge (risk difference 0.09, 95% CI = 0.01 to 0.17) and patients with mild severity of red eye (risk difference 0.10, 95% CI = 0.02 to 0.18), while the type of control used (placebo drops versus nothing) showed a statistically significant interaction (P=0.03)
Conclusion: acute conjunctivitis seen in primary care can be thought of as a self-limiting condition, with most patients getting better regardless of antibiotic therapy. Patients with purulent discharge or a mild severity of red eye may have a small benefit from antibiotics. Prescribing practices need to be updated, taking into account these results
e545-e548
Jefferis, Joanna
cf6b7ee0-7071-4cd7-8990-39afa74e2360
Perera, Rafael
e99a2819-c326-461c-8526-980b64458c22
Everitt, Hazel
80b9452f-9632-45a8-b017-ceeeee6971ef
van Weert, Henk
c16c62bf-6d7c-4c22-8103-b7dfd957ff6e
Rietveld, Remco
b4bfb9d8-1933-471a-be62-cb9b8bd16bbb
Glasziou, Paul
c1890d0d-7bb1-45c9-9841-5a38c834eac2
Rose, Peter
5df71431-cc13-43ac-86da-8f26fa607b33
September 2011
Jefferis, Joanna
cf6b7ee0-7071-4cd7-8990-39afa74e2360
Perera, Rafael
e99a2819-c326-461c-8526-980b64458c22
Everitt, Hazel
80b9452f-9632-45a8-b017-ceeeee6971ef
van Weert, Henk
c16c62bf-6d7c-4c22-8103-b7dfd957ff6e
Rietveld, Remco
b4bfb9d8-1933-471a-be62-cb9b8bd16bbb
Glasziou, Paul
c1890d0d-7bb1-45c9-9841-5a38c834eac2
Rose, Peter
5df71431-cc13-43ac-86da-8f26fa607b33
Jefferis, Joanna, Perera, Rafael, Everitt, Hazel, van Weert, Henk, Rietveld, Remco, Glasziou, Paul and Rose, Peter
(2011)
Acute infective conjunctivitis in primary care: Who needs antibiotics? An individual patient data meta-analysis.
British Journal of General Practice, 61 (590), .
(doi:10.3399/bjgp11X593811).
(PMID:22152728)
Abstract
Background: acute infective conjunctivitis is a common problem in primary care, traditionally managed with topical antibiotics. A number of clinical trials have questioned the benefit of topical antibiotics for patients with acute infective conjunctivitis
Aim: to determine the benefit of antibiotics for the treatment of acute infective conjunctivitis in primary care and which subgroups benefit most
Design: an individual patient data meta-analysis
Method: relevant trials were identified and individual patient data gathered for meta-analysis and subgroup analysis
Results: three eligible trials were identified. Individual patient data were available from all primary care trials and data were available for analysis in 622 patients. Eighty per cent (246/308) of patients who received antibiotics and 74% (233/314) of controls were cured at day 7. There was a significant benefit of antibiotics versus control for cure at seven days in all cases combined (risk difference 0.08, 95% confidence interval (CI) = 0.01 to 0.14). Subgroups that showed a significant benefit from antibiotics were patients with purulent discharge (risk difference 0.09, 95% CI = 0.01 to 0.17) and patients with mild severity of red eye (risk difference 0.10, 95% CI = 0.02 to 0.18), while the type of control used (placebo drops versus nothing) showed a statistically significant interaction (P=0.03)
Conclusion: acute conjunctivitis seen in primary care can be thought of as a self-limiting condition, with most patients getting better regardless of antibiotic therapy. Patients with purulent discharge or a mild severity of red eye may have a small benefit from antibiotics. Prescribing practices need to be updated, taking into account these results
This record has no associated files available for download.
More information
Published date: September 2011
Organisations:
Community Clinical Sciences, Primary Care & Population Sciences
Identifiers
Local EPrints ID: 185581
URI: http://eprints.soton.ac.uk/id/eprint/185581
ISSN: 0960-1643
PURE UUID: 63587ebb-a13f-448f-b148-7f128395de9f
Catalogue record
Date deposited: 10 May 2011 14:06
Last modified: 15 Mar 2024 03:04
Export record
Altmetrics
Contributors
Author:
Joanna Jefferis
Author:
Rafael Perera
Author:
Henk van Weert
Author:
Remco Rietveld
Author:
Paul Glasziou
Author:
Peter Rose
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics